Business
Thiogenesis Therapeutics, Corp. to Present at the Life Sciences Virtual Investor Forum December 11th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comSAN DIEGO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) (“Thiogenesis” or the “Company”), a clinical-stage biotechnology company developing next-generation sulfur-based prodrugs for rare mitochondrial and metabolic diseases, today announced that Brook Riggins, CFO and director, will present live at Life Science
About this update from Thiogenesis Therapeutics Corp
[{"type":"image","alt":"Virtual Investor Conferences; Thiogenesis Therapeutics, Corp.","displaySize":"","headline":null,"caption":"Virtual Investor Conferences; Thiogenesis Therapeutics, Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":200,"url":"https://media.zenfs.com/en/globenewswire.com/7e30d4a58a8d048d2ee1986670b581bc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wFNFO9V7weOyJzKv3Grwwg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI4MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7e30d4a58a8d048d2ee1986670b581bc","width":300,"height":200}},"lazy":false},{"type":"text","content":"Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com","length":140,"tagName":"p"},{"type":"text","content":"SAN DIEGO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) (“Thiogenesis” or the “Company”), a clinical-stage biotechnology company developing next-generation sulfur-based prodrugs for rare mitochondrial and metabolic diseases, today announced that Brook Riggins, CFO and director, will present live at Life Sciences Virtual Investor Forum hosted by VirtualInvestorConferences.com, on December 11th.","length":449,"tagName":"p"},{"type":"text","content":"DATE: December 11th TIME: 12:00 PM ETLINK: REGISTER HEREAvailable for 1x1 meetings: December 17. Schedule 1x1 Meetings here ","length":126,"tagName":"p"},{"type":"text","content":"This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.","length":260,"tagName":"p"},{"type":"text","content":"It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.","length":137,"tagName":"p"},{"type":"text","content":"Learn more about the event at www.virtualinvestorconferences.com.","length":65,"tagName":"p"},{"type":"text","content":"Recent Thiogenesis Highlights","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Announced Plans to file an IND for a Phase 3 cystinosis clinical trial in the US","length":80,"tagName":"p"}]},{"val":[{"type":"te...